English

Afinum Management acquires significant stakes in two laser companies

846
2024-08-08 11:35:32
See translation

Recently, Afinum Management, a private equity firm based in Munich, Germany, has acquired a large stake in two laser companies, with the intention of opening up new laser markets by combining the strengths of three parties.

According to media reports, the two companies are ARC Laser in Germany and GNS neo Laser in Israel, and Afinum has agreed with the founders of the two companies that the acquisition of this stake will be part of a deal that will see the three parties invest in the formation of a consolidated leader in medical laser technology, with the founders of the two laser companies making a further investment in the new company. The founders of the two laser companies will make a further investment in the new company.

Angela Thyzel is the founder of ARC Laser, a company that since its establishment in 1996 has focused on the development of high-quality standard lasers for gentle and effective applications in modern medicine, with a portfolio of laser devices for ophthalmology, ENT, general surgery and veterinary medicine, currently used in a wide range of medical surgical procedures.

GNS neo Laser, also a company with advanced medical laser technology, is an expert in endovenous laser ablation, laser devices for anorectal applications, and fiber optics, and was founded by Gil Shapira, and is now a leader in their respective medical laser solutions, which are contributing to significant advances in patient care and treatment outcomes.

The new joint venture, named MedTech Laser Group, will see the two companies collaborate on technology development, sales and marketing, capitalizing on the growing medical laser market and their own deep technological expertise to drive the new company's rapid growth.

The three companies are really targeting the rapidly growing market for ophthalmic and surgical lasers, which is being driven by long-term trends such as the aging of the population, the rising prevalence of related diseases, and advances in laser treatment technology. In addition, Afinum claims to be pursuing further opportunities to expand the company's technology and product portfolio in the future, both organically and through strategic add-on acquisitions.

Source: OFweek

Related Recommendations
  • Han's Laser senior management resigns

    Just now, Han's Laser Technology Industry Group Co., Ltd. announced the resignation of senior management personnel. The board of directors recently received a written resignation report from Mr. Zhao Guanghui, the deputy director of the company's management and decision-making committee. Mr. Zhao Guanghui has applied to resign from his position as deputy director of the company's management and de...

    06-09
    See translation
  • New type of "dynamic static dual sensing" charge coupled phototransistor

    With the development of cutting-edge technologies such as automatic guidance and embodied intelligence, machine vision has put forward higher requirements for image acquisition, requiring precise recording of static images and the ability to sensitively capture dynamic changes in the scene. The existing dynamic and active pixel sensor technology integrates two functions: dynamic event detection an...

    04-17
    See translation
  • Manz AG officially announces its application for bankruptcy restructuring

    Last month, Manz AG officially announced that the company is about to undergo bankruptcy restructuring. The board of directors of the company believes that due to insufficient liquidity and excessive debt, Manz AG intends to apply for bankruptcy proceedings in accordance with bankruptcy laws. The application is expected to be submitted in the next few days. Manz AG is headquartered in Reutlingen...

    01-07
    See translation
  • Marvel Fusion announces completion of € 50 million B+round funding

    On March 28th, Marvel Fusion, a laser fusion company from Munich, Germany, announced the completion of a B+round financing of 50 million euros, bringing the total amount of this round of financing to 113 million euros. It is reported that the company's cumulative financing has reached 385 million euros, making it the largest fusion company in Europe in terms of financing scale. This capital incr...

    03-31
    See translation
  • Jenoptik will invest millions of dollars to expand its optical manufacturing facilities

    A high-end manufacturing facility for semiconductor optics will be expanded at Jenoptik’s production campus in Jena, Germany. The photonics group will invest a sum in the low double-digit million euro range starting at the end of 2025.On the expanded production areas, Jenoptik will manufacture sophisticated, high-quality optical components that are mainly used in the semiconductor equipment indust...

    09-13
    See translation